Future pharmaceutical reform ready for final EU Parliament vote
Innovative medicines regulations require that products be more environmentally friendly in the future and cap the data protection period.
There is a consensus among EU parliamentarians for a comprehensive pharmaceutical reform, which is now facing its crucial vote in the EU Parliament, aimed at promoting innovation and increasing the security of supply and availability of medicines, especially within new types of medicines and antibiotics, the EU Parliament writes in a statement.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
EU Commission launches Critical Medicines Alliance
For subscribers
